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Fig. 1 a : Mammography revealed irregularly shaped nodule in fatty breast tissue.
 b : Ultrasonography before therapy revealed irregularly shaped tumor 22 34 mm in size in right inner upper quadrant.
 c : Aspiration cytology revealed loosely connected atypical cell clusters, suggesting solid tubular carcinoma.
 d : Ultrasonography 1 year after therapy showed that tumor had been reduced to 13 15 mm in size.
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Fig. 2 a : Mammography revealed that irregularly shaped nodule had invaded epithelium of fatty breast tissue.
 b : Ultrasonography revealed irregularly shaped tumor 20 30 mm in size in right inner upper quadrant. Invasion of epithe-
lium was also observed.
 c : Microscopic ndings revealed solid tubular carcinoma. HE 10
 d : Immunohistochemical ndings were positive for Her 2 Score 3 . 10
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Fig. 3 a : Mammography revealed that irregularly shaped tumor with spicula had invaded epithelium.
 b : Ultrasonography revealed irregularly shaped tumor 18 12 22 mm in size. Tumor had invaded epithelium.
 c : Microscopic ndings revealed apocrine carcinoma. HE 10
 d : Immunohistochemical ndings were positive for Her2 Score 3 . 10
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Abstract
Here, we describe treatment for breast cancer speci cally tailored to the needs of the patient in three nonagenarians. Case 
1 was a 92-year-old woman with a T2N0M0 solid-tubular carcinoma who was living alone. Administration of aromatase 
inhibitor over a 24-month period resulted in a reduction in the size of the tumor. Case 2 was a 92-year-old woman in whom a 
solid tubular carcinoma had invaded the epithelium. Partial resection without adjuvant therapy controlled tumor growth for 15 
months without recurrence. Case 3 was a 95-year-old woman with a pacemaker in whom an apocrine carcinoma had invaded 
the epithelium. Partial resection without adjuvant therapy controlled tumor growth for 13 months without recurrence. Treat-
ment should be selected taking into account the patient s life environment, additional diseases, and functional status.
Breast cancers involving invasion of the epithelium should be removed immediately while keeping the procedure as non-inva-
sive as possible. Although aromatase inhibitor is suitable for hormone-sensitive breast cancer in the elderly, bisphosphonate 
should also be prescribed to avoid bone-related adverse events.
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